Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Bicyclist Injured in Crash at N. Eastman Avenue and E. 1st Street


Vehicle Hits Bicycle in Los Angeles Accident 

Los Angeles, CA (April 6, 2020) – A bicyclist suffered serious injuries in a crash in Los Angeles. The accident occurred on the evening of April 6 at N. Eastman Avenue and E. 1st Street.

A bicycle and a Honda Accord collided at the intersection. The bicyclist was taken to a local hospital with serious injuries.

#Los Angeles

#90063


May 6, 2020

Leroy Jefferson, Jr. Killed in Crash on Interstate 5 Near Grapevine Road

Motorcycle Rear-Ends Big Rig in Fatal Lebec Accident...


February 7, 2020

Man Killed in Hit and Run Crash at Hill Street and W. Adams Boulevard

Man Arrested for Causing Fatal Los Angeles Accident ...


October 14, 2019

2 Killed, 1 Injured in Crash at Pioneer Boulevard and Carson Street

3 Vehicles Involved in Fatal Hawaiian Gardens Accident Hawaiian Gardens, CA (Oc...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.